{"id":"W2153935627","doi":"10.1093/jnci/djn134","title":"Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma","year":2008,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1664,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Medicine; Clinical endpoint; Clinical trial; Surrogate endpoint; Clinical study design; Sorafenib; Oncology; Internal medicine; Population; Randomized controlled trial; Hepatocellular carcinoma; Liver function; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.3268367,0.003497924,0.007466744,0.00316568,0.00195483,0.006738568,0.002496904,0.006610597,0.006714321],"category_scores_gemma":[0.3413953,0.001732798,0.005111354,0.003163823,0.004183251,0.003441676,0.004116383,0.007247642,0.001901033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004000843,"about_ca_system_score_gemma":0.009811035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003277436,"about_ca_topic_score_gemma":0.0003895715,"domain_scores_codex":[0.3910155,0.5579051,0.03042312,0.006473552,0.01178409,0.00239862],"domain_scores_gemma":[0.7399868,0.1597591,0.039731,0.03110836,0.0222857,0.007128994],"domain_codex":"methods","domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.2913642,0.004886177,0.01167006,0.03833859,0.0130631,0.0004993756,0.001704922,0.01575652,0.003125999,0.08844951,0.02381861,0.5073229],"study_design_scores_gemma":[0.3389319,0.09822349,0.01822101,0.02460393,0.01113652,0.0005639902,0.000639391,0.04161403,0.006710422,0.2278513,0.2307633,0.0007407567],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"review","genre_scores_codex":[0.02678733,0.04096675,0.2445345,0.009499555,0.01539703,0.6375824,0.002516348,0.001048436,0.02166768],"genre_scores_gemma":[0.06035841,0.003589056,0.1188619,0.003062509,0.001079458,0.8108521,0.0005008756,0.0001072384,0.00158854],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.3268367,"threshold_uncertainty_score":0.8301302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6514346438688952,"score_gpt":0.4969074105035567,"score_spread":0.1545272333653385,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}